These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 12153739)
21. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745 [TBL] [Abstract][Full Text] [Related]
22. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults. Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648 [TBL] [Abstract][Full Text] [Related]
23. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH. Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003 [TBL] [Abstract][Full Text] [Related]
24. Serum leptin levels in acromegalic patients before and during somatostatin analogs therapy. Baldelli R; Durante C; D'Amico E; Diacono F; Tamburrano G; Casanueva FF J Endocrinol Invest; 2003 Dec; 26(12):1219-24. PubMed ID: 15055476 [TBL] [Abstract][Full Text] [Related]
25. Ghrelin secretion in severely obese subjects before and after a 3-week integrated body mass reduction program. Morpurgo PS; Resnik M; Agosti F; Cappiello V; Sartorio A; Spada A J Endocrinol Invest; 2003 Aug; 26(8):723-7. PubMed ID: 14669825 [TBL] [Abstract][Full Text] [Related]
26. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395 [TBL] [Abstract][Full Text] [Related]
27. Plasma levels of acylated ghrelin during an oral glucose tolerance test in obese children. Lányi E; Csernus K; Erhardt E; Tóth K; Urbán B; Lénárd L; Molnár D J Endocrinol Invest; 2007 Feb; 30(2):133-7. PubMed ID: 17392603 [TBL] [Abstract][Full Text] [Related]
28. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure? Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870 [TBL] [Abstract][Full Text] [Related]
29. Plasma levels of total and active ghrelin in acromegaly and growth hormone deficiency. Jarkovská Z; Rosická M; Marek J; Hána V; Weiss V; Justová V; Lacinová Z; Haluzík M; Krsek M Physiol Res; 2006; 55(2):175-181. PubMed ID: 15910166 [TBL] [Abstract][Full Text] [Related]
30. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Malik IA; English PJ; Ghatei MA; Bloom SR; MacFarlane IA; Wilding JP Clin Endocrinol (Oxf); 2004 Jan; 60(1):137-41. PubMed ID: 14678299 [TBL] [Abstract][Full Text] [Related]
32. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. Misra M; Miller KK; Herzog DB; Ramaswamy K; Aggarwal A; Almazan C; Neubauer G; Breu J; Klibanski A J Clin Endocrinol Metab; 2004 Apr; 89(4):1605-12. PubMed ID: 15070919 [TBL] [Abstract][Full Text] [Related]
33. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity. Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623 [TBL] [Abstract][Full Text] [Related]
34. Ghrelin concentrations in acromegalic patients in relation to the administered therapy. Wasko R; Jaskula M; Komarowska H; Zamyslowska H; Sowinski J; Waligorska-Stachura J Neuro Endocrinol Lett; 2006; 27(1-2):162-8. PubMed ID: 16670671 [TBL] [Abstract][Full Text] [Related]
35. Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects. Plöckinger U; Holst JJ; Messerschmidt D; Hopfenmüller W; Quabbe HJ Eur J Endocrinol; 1999 Jun; 140(6):538-44. PubMed ID: 10377503 [TBL] [Abstract][Full Text] [Related]
36. Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility. Arafat AM; Müller L; Möhlig M; Mayr B; Kremenevskaya N; Pfeiffer AF; Buchfelder M; Schöfl C Clin Endocrinol (Oxf); 2011 Nov; 75(5):685-91. PubMed ID: 21575028 [TBL] [Abstract][Full Text] [Related]
37. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. Giordano R; Picu A; Pagotto U; De Iasio R; Bonelli L; Prodam F; Broglio F; Marafetti L; Pasquali R; Maccario M; Ghigo E; Arvat E Eur J Endocrinol; 2005 Oct; 153(4):535-43. PubMed ID: 16189175 [TBL] [Abstract][Full Text] [Related]